BUE Equity Snapshot

LLY Weekly Equity Report

Eli Lilly and Company

Interactive chart JSON snapshot
Latest Close 30,340 ARS 12 Jun 2026
1W Return -0.7% latest completed week
4W Return 14.0% short-term follow-through
12W Return 28.0% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
Company Brief

What the company does

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers …

Snapshot

What the weekly tape is saying

LLY closed the latest completed week at 30,340 ARS. The 4-week return is 14.0% and the 12-week return is 28.0%. Trend Signal is inactive, Market Dynamics is 1.03. Setup signature: Early recovery watch with a 63/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 11.4%
Volume 1.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 26 Persistence of active Trend Signal over the last year and current streak.
Momentum 100 Blend of 4-week and 12-week follow-through.
Dynamics 100 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 32 Relative leadership and short-term RS change.
Volume 52 Participation compared with the 13-week volume baseline.
Risk Control 69 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
27,228 ARS
Vs Trend Line
11.4%
Fair Value
27,815 ARS
Vs Fair Value
9.1%
52W High
31,960 ARS
52W Low
14,850 ARS
Drawdown
-5.1%
Range Position
90.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -0.7%
4W 14.0%
12W 28.0%
26W 9.4%
52W 74.4%

Trend read

Active Streak
0 weeks
52W Active Weeks
25
52W Active Breadth
48.1%
Sector Scope
AR Healthcare
Sector Rank
13 of 20
Sector Percentile
36.8%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.03
4W MD Change
726.8%
Relative Strength
-2.61
4W RS Change
-133.4%
Expectation
Positive
Probability
61.12%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
74.0K
13W Average
60.1K
52W Average
61.9K
Vs 13W
1.2x
Vs 52W
1.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.8%
52W Volatility
6.1%
Upside Weeks
28
Downside Weeks
23
Downside Breadth
44.2%
Avg Gain / Loss
5.4% / -3.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
BUE
Country
AR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
ARS
Market Cap
6402.7B

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 30,340 ARS -0.7% 27,228 ARS 27,815 ARS 1.03 -2.61 74.0K Off
5 Jun 2026 30,560 ARS 4.4% 27,131 ARS 27,803 ARS 0.87 6.82 91.2K Off
29 May 2026 29,280 ARS 3.6% 26,916 ARS 27,785 ARS 0.54 0.17 92.5K Off
22 May 2026 28,260 ARS 6.2% 26,712 ARS 27,770 ARS 0.16 8.06 67.9K Off
15 May 2026 26,620 ARS 5.5% 26,541 ARS 27,757 ARS -0.16 7.80 94.9K Off
8 May 2026 25,240 ARS 0.9% 26,393 ARS 27,760 ARS -0.46 0.58 73.2K Off
1 May 2026 25,020 ARS 5.7% 26,299 ARS 27,762 ARS -0.71 -2.14 61.6K Off
24 Apr 2026 23,660 ARS -2.0% 26,227 ARS 27,759 ARS -0.86 -7.77 60.5K Off
17 Apr 2026 24,150 ARS -2.1% 26,074 ARS 27,752 ARS -1.01 -7.47 48.5K Off
10 Apr 2026 24,670 ARS -3.0% 25,969 ARS 27,736 ARS -1.07 -8.68 31.3K Off
3 Apr 2026 25,440 ARS 10.1% 25,812 ARS 27,697 ARS -1.08 -5.75 32.6K Off
27 Mar 2026 23,100 ARS -2.6% 25,565 ARS 27,653 ARS -0.95 -8.10 17.8K Off
20 Mar 2026 23,710 ARS -8.2% 25,386 ARS 27,615 ARS -0.89 -3.25 35.1K Off
13 Mar 2026 25,840 ARS -1.1% 25,159 ARS 27,567 ARS -0.90 8.92 17.9K On